BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 12860944)

  • 21. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
    Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
    Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.
    Richter EN; Oevermann K; Buentig N; Storkel S; Dallmann I; Atzpodien J
    J Urol; 2002 Aug; 168(2):460-4. PubMed ID: 12131288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
    Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter study of human immunodeficiency virus-related germ cell tumors.
    Powles T; Bower M; Daugaard G; Shamash J; De Ruiter A; Johnson M; Fisher M; Anderson J; Mandalia S; Stebbing J; Nelson M; Gazzard B; Oliver T
    J Clin Oncol; 2003 May; 21(10):1922-7. PubMed ID: 12743144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
    Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
    Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognosis value of p53, C-erB-2 and Ki67 proteins in ovarian carcinoma].
    Frutuoso C; Silva MR; Amaral N; Martins I; De Oliveira C; De Oliveira HM
    Acta Med Port; 2001; 14(3):277-83. PubMed ID: 11552325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index.
    Jalava P; Kuopio T; Juntti-Patinen L; Kotkansalo T; Kronqvist P; Collan Y
    Histopathology; 2006 May; 48(6):674-82. PubMed ID: 16681683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.